99mtc(v) and 188re(v) dimercaptosuccinic acid (dmsa) quality control: an evaluation of different suppliers and labelling conditions.
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Poster
- By: SAVIO, Eduardo (Facultad de Química, Montevideo, Uruguay)
- Co-author(s): Savio, Eduardo (Facultad de Química, MONTEVIDEO, Uruguay)
Piuma, Lourdes (Facultad de Química, MONTEVIDEO, Uruguay)
Paolino, Andrea (Facultad de Química, MONTEVIDEO, Uruguay)
99mTc(V)-DMSA has been widely adopted as the imaging agent of choice, mainly for medullary thyroid carcinoma. Rhenium analogue 188Re(V)-DMSA has also been evaluated for targeted radiotherapy of cancer. After labelling procedure following species were reported: different isomers as anti, syn-endo and syn-exo, but also other species could be.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.